COVID-19 Impact on Unilever, H1 2020 Update
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
COVID-19 Impact on Unilever, H1 2020 Update
COVID-19 Impact on Unilever, H1 2020 Update June 26th, 2020 based on market analysis and brand diversification by industry and geography
While all companies in the consumer goods sector will see a major upheaval as a result of the disease, Unilevers sales show a level of diversity in both product and regional terms that leaves it relatively well positioned to ride out the pandemic. A giant in the sector, it will potentially see a lot of sales lost at the retail level, but its implied 4.9% decline in brand sales in 2020 compared to what was predicted before COVID-19 is moderate compared to some. However, achieving this level of performance will require strong execution in food and household products, or a very strong performance in the latter relative to its competitors. It has advantages of scale and reach that may allow it to achieve this, if it reacts effectively to the crisis.
Scope
- Assuming its performance is in line with general trends, Unilever has $4.9bn of retail sales at risk due to COVID-19, but it will need to effectively target food and household goods, or dramatically out-perform the market in cosmetics and toiletries, to avoid a shaper fall
- Unilevers diversification offers some level of relative resilience against the effects on brand sales
- Western Europe is relatively unaffected, but sector presence in key regions shows that billions in dollar sales are at risk
- Despite early positive signs, Unilevers cosmetic and toiletries business is set to suffer from lockdown, social distancing, and home-working trends
- However, a lack of diversification in Unilevers food business means that it should focus heavily on defensive strategies in its core areas
- Foodservice shutdowns and social distancing place beverage sales under pressure
- Household products offer a silver lining for the company
Reasons to Buy
- Understand the challenges and opportunities for a specific company in order to tap into what is really impacting the industry.
- Gain a broader appreciation of the industry by gaining insights from both within and outside of your sector.
- Access valuable strategic take-outs to help direct future decision-making and inform new product development.
COVID-19 Impact on Unilever, H1 2020 Update June 26th, 2020 based on market analysis and brand diversification by industry and geography
While all companies in the consumer goods sector will see a major upheaval as a result of the disease, Unilevers sales show a level of diversity in both product and regional terms that leaves it relatively well positioned to ride out the pandemic. A giant in the sector, it will potentially see a lot of sales lost at the retail level, but its implied 4.9% decline in brand sales in 2020 compared to what was predicted before COVID-19 is moderate compared to some. However, achieving this level of performance will require strong execution in food and household products, or a very strong performance in the latter relative to its competitors. It has advantages of scale and reach that may allow it to achieve this, if it reacts effectively to the crisis.
Scope
- Assuming its performance is in line with general trends, Unilever has $4.9bn of retail sales at risk due to COVID-19, but it will need to effectively target food and household goods, or dramatically out-perform the market in cosmetics and toiletries, to avoid a shaper fall
- Unilevers diversification offers some level of relative resilience against the effects on brand sales
- Western Europe is relatively unaffected, but sector presence in key regions shows that billions in dollar sales are at risk
- Despite early positive signs, Unilevers cosmetic and toiletries business is set to suffer from lockdown, social distancing, and home-working trends
- However, a lack of diversification in Unilevers food business means that it should focus heavily on defensive strategies in its core areas
- Foodservice shutdowns and social distancing place beverage sales under pressure
- Household products offer a silver lining for the company
Reasons to Buy
- Understand the challenges and opportunities for a specific company in order to tap into what is really impacting the industry.
- Gain a broader appreciation of the industry by gaining insights from both within and outside of your sector.
- Access valuable strategic take-outs to help direct future decision-making and inform new product development.
TABLE OF CONTENTS
COVID-19 impact analysis on Unilever - key findings as of 26th June, 2020
Geographic spread analysis - COVID-19 vs Unilevers brand sales
The impact of COVID-19 on Unilevers regional sectors
Unilevers 2020 exposure: brand sales at risk by region and sector
Contact Us
RELATED REPORTS
Restaurant Experiences Post-COVID-19 - Dining Out is likely to be Reviewed, Refreshed, or Completely Re-Imagined after the Pandemic - Foodservice Insights and Trends
Restaurant Experiences Post-COVID-19 - Dining Out is likely to be Reviewed, Refreshed, or Completely Re-Imagined after the Pandemic - Foodservice Insights and TrendsThe post-pandemic dining experience will undergo a significant
View ReportGlobal Tea Market (2021 Edition) – Analysis By Type (Green, Black, Oolong, Herbal, Others), Packaging Type, Distribution Channel, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2021-2026)
Executive The Global Tea Market was valued at USD 21.9 billion in the year 2020. With the increased demand of tea in highly populated countries such as China and India,
View ReportCoronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 Update
Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 UpdateThis 62-page PowerPoint based report gives an important update to the previous year with an expert analysis on how COVID-19 is
View ReportGlobal Peptide Therapeutics Market (2021 Edition) – Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced), Application,, By Region, By Country: Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)
Executive The Global Peptide Therapeutics Market is valued at USD 32.1 Billion in the year 2020. The growth of Peptide Therapeutics is directly associated with drug development. New drug discovery
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
